NCT02244346已完成不适用
Secotex®: Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 811
- 主要终点
- Number of patients with adverse events
研究概览
简要总结
Study to evaluate the safety profile of Secotex® in the improvement of the symptoms of Benign Prostatic Hyperplasia in real clinical practice
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Patients of any age with a diagnosis of symptomatic Benign Prostatic Hyperplasia (BPH)
- •Patients with symptoms, that according to physician require medical treatment to improve quality of life
- •Patients could be naive to treatment or could be on treatment with other drugs but have not responded adequately to treatment
排除标准
- •Patients with known hypersensitivity to Tamsulosin, or any other component of the product
- •Patients with a history of orthostatic hypotension or severe liver failure
研究组 & 干预措施
Benign prostatic hyperplasia patients
干预措施: Secotex® (Drug)
结局指标
主要结局
Number of patients with adverse events
时间窗: up to 6 months
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
Safety Profile of Secotex ® in Patients With Benign Prostatic HyperplasiaProstatic HyperplasiaNCT02245529Boehringer Ingelheim982
已完成
不适用
Protocol for the Specified Clinical Experience Investigation on the Single Use of Casodex® Tablet 80 mgProstate CancerNCT00919477AstraZeneca712
已完成
不适用
Clinical Evaluation of ExoDx Prostate(IntelliScore) in Men Presenting for Initial Prostate BiopsyUrologic CancerNCT04720599Exosome Diagnostics, Inc.120
终止
不适用
ExoDx Prostate Evaluation in Prior Negative Prostate Biopsy SettingProstate CancerNCT04357717Exosome Diagnostics, Inc.150
已完成
2 期
Safety and Efficacy of POMx Capsules in Men With Recurrent Prostate Cancer: An 18-Month StudyRecurrent Prostate CancerNCT01220817POM Wonderful LLC104